Search results for "Hepatitis"


 
Results 31 - 40 of about 199 for "Hepatitis".
Sort by: Relevance | Newest | Oldest

The waning and boosting of COVID-19 immunity

ACP and Annals of Internal Medicine's sixth COVID-19 forum examined progress amid the pandemic in the past year.
https://immattersacp.org/archives/2021/11/the-waning-and-boosting-of-covid-19-immunity.htm
1 Nov 2021

MKSAP Quiz: 4 days of fever and arthralgia

A 43-year-old man is evaluated for 4 days of fever and arthralgia, as well as a raised purple rash over his lower extremities of 1 week's duration. He is a current intravenous drug user. He has no other medical problems and takes no medications. Following a physical exam, lab studies, and skin findings, what is the most appropriate treatment?
https://immattersacp.org/archives/2019/05/mksap-quiz-4-days-of-fever-and-arthralgia.htm
1 May 2019

MKSAP Quiz: Surveillance ultrasound for hepatocellular carcinoma

A 57-year-old man is evaluated during a routine examination. His medical history is notable for chronic hepatitis C infection with cirrhosis, which was diagnosed 3 years ago. He undergoes surveillance ultrasound for hepatocellular carcinoma every 6 months. Following a physical exam and ultrasound that reveals three new liver masses, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2017/12/19/3.htm
19 Dec 2017

MKSAP Quiz: Joint pain, rash, and weakness

A 61-year-old woman is evaluated for joint pain, a rash on her legs, and weakness. She has chronic genotype 1 hepatitis C viral infection. She takes no medication. Following a physical exam and lab studies, what is the most appropriate treatment?
https://immattersacp.org/archives/2019/06/mksap-quiz-joint-pain-rash-and-weakness.htm
1 Jun 2019

HIV and chronic HBV/HCV co-infection may increase non-Hodgkin's lymphoma risk

Co-infected patients with poor immune status or restoration are at high risk for non-Hodgkin's lymphoma and death and deserve high priority for access to well-tolerated, interferon-free, direct-acting antiviral treatment programs, study authors noted.
https://immattersacp.org/weekly/archives/2016/10/18/2.htm
18 Oct 2016

MKSAP Quiz: 8-year history of joint pain

A 50-year-old man is evaluated for an 8-year history of joint pain, particularly in the hands, and progressively worsening fatigue. Medical history is otherwise unremarkable. He takes ibuprofen as needed. There are swelling and tenderness of the second and third metacarpophalangeal (MCP) joints bilaterally, and tenderness but no swelling of the fourth and fifth MCP joints bilaterally. There is bony hypertrophy of the first MCP joints and knees bilaterally. The proximal interphalangeal joints and wrists are normal. Following a physical exam, lab studies, and a radiograph, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/archives/2017/05/mksap.htm
1 May 2017

Naltrexone or acamprosate effective for alcohol use disorder

The number needed to treat to prevent one person from returning to any drinking was 11 for acamprosate and 18 for oral naltrexone, a recent systematic review and meta-analysis found.
https://immattersacp.org/weekly/archives/2023/11/14/1.htm
14 Nov 2023

‘Gold standard’ underused for substance misuse

While effective medications to treat opioid addiction are available in primary care, few physicians prescribe buprenorphine or naltrexone, and few would obtain the Drug Enforcement Administration (DEA) waiver to prescribe buprenorphine.
https://immattersacp.org/archives/2020/11/gold-standard-underused-for-substance-misuse.htm
1 Nov 2020

HCV patients being treated for opioid addiction appear to benefit from antiviral therapy

Patients with hepatitis C virus (HCV) infection who were receiving opioid-agonist therapy (such as methadone or buprenorphine) and treatment with elbasvir-grazoprevir had high rates of sustained virologic response regardless of continued drug use, an industry-funded study found.
https://immattersacp.org/weekly/archives/2016/08/09/4.htm
9 Aug 2016

New meningitis vaccine, hepatitis C drug approved

Recalls and approvals.
https://immattersacp.org/archives/2015/01/fda.htm
1 Jan 2015

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next